Company: KNRX
Filing Date: 2025-06-12
Form Type: F-1/A
Source: 0001641172-25-014801
Chunk: 5

Company: KNOREX LTD.
Filing Date: 2025-06-12
Form: F-1/A
Chunk 5
---
 Company is an exempted
company incorporated on May 9, 2023, under the laws of the Cayman Islands with no substantial operations of its own other than holding
all the outstanding share capital of its subsidiaries. For the years ended December 31, 2024 and 2023 and up to the date
hereof, we have been conducting our business through Knorex Pte. Ltd. (“Knorex SG”), a company incorporated under the laws
of Singapore, which owns 100% equity interests in our operating subsidiaries in the United States, Malaysia, and China, and 99.99% and
99%, respectively, of the equity interests in our operating subsidiaries in India and Vietnam. The Company implemented a reverse capitalization
on September 30, 2024 by way of entering into a restructuring agreement with the shareholders of Knorex SG (“Reorganization”),
upon the completion of which the current shareholders of Knorex SG and certain other persons became shareholders of the Company and as
of the date of this prospectus, the Reorganization was completed and the Company now owns 100% of Knorex SG as the same shareholders
effectively control our Group (including the Company and its subsidiaries) before and after the Reorganization, it has been treated as
a reorganization of entities under common control, and our financial statements have accounted for the consolidation of the Company and
its subsidiaries at historical cost and have been prepared on the basis as if the Reorganization had become effective as of January 1,
2021. For a detailed discussion, see note 1 to our consolidated financial statements included in this prospectus.

As of December 31,
2024, the Company had 22,477,825 Class A Ordinary Shares and 4,780,575 Class B Ordinary Shares issued and outstanding.

| 4 |

<div align='center'>PROSPECTUS SUMMARY</div>

This summary highlights selected information from this prospectus. It may not contain all the information that is important to you. You should carefully read the entire prospectus and the other documents referred to in this prospectus before making an investment in our Class A Ordinary Shares. You should carefully consider, among other things, our consolidated financial statements and the related notes and the sections titled “Risk Factors,” “Business” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included elsewhere in this prospectus. For additional information, see “Where You Can Find More Information” in this prospectus.

Overview